Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,288.00    68.00 (5.57%)
Bid:
1,276.00
Ask:
1,280.00
Spread: 4.00 (0.313%)
Market Cap: £590.24m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Announcement

2 Jun 2017 07:00

RNS Number : 9286G
Cohort PLC
02 June 2017
 

02 June 2017

 

Cohort plc

("Cohort")

 

Contract Announcement

 

MCL contracted to supply further Hearing Protection and Communication Ancillaries

to the UK Ministry of Defence (MOD)

 

Cohort, the independent technology group, is pleased to announce that its subsidiary MCL (Marlborough Communications Ltd) has been awarded two contracts by the MOD to supply and support hearing protection systems and communication ancillaries for land, maritime and air applications, worth a combined £5.5 million. The two orders comprise:

· a follow-on order worth £3.2 million for Tactical Hearing Protection Systems for Dismounted Close Combat Users (THPS DCCU) that provide hearing protection for RAF, Royal Navy and Reservist personnel;

· a new contract to provide In Ear Communication Devices (IECD) for RAF pilots and air crew, with an initial value of £2.3 million over five years with options for a further two years.

The contracts follow previous MOD contract awards for hearing protection announced in 2015 and more recently in March 2017. The THPS DCCU solution being supplied by MCL has been developed in partnership with INVISIO Communications, a leading Danish audio technology company, whilst the IECD for RAF and air crews is being developed in conjunction with Banbury-based Advanced Communication Solutions (ACS).

Andy Thomis, Chief Executive of Cohort, said:

"This is another great success for MCL, and its partners, in hearing protection. These two further contracts bring the total number of recent awards to four with a combined value to the Group of around £30 million, further cementing MCL's position as the MOD's leading supplier of hearing protection systems for the military.

 

"This and other recent contract awards enhance the visibility of future Group revenue".

 

 

Ends

 

For further information, please contact:

 

 

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

 

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security.

www.mass.co.uk

 

MCL is an expert in the sourcing, design, integration and support of communications and surveillance technology for the defence and security markets.

www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets.

www.eid.pt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUAANRBBANRAR
Date   Source Headline
14th Mar 20225:11 pmRNSDirector/PDMR Shareholding
7th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20223:32 pmRNSHolding(s) in Company
28th Feb 20222:55 pmRNSTotal Voting Rights
25th Feb 202212:15 pmRNSBlock listing Interim Review
23rd Feb 20227:00 amRNSSEA AWARDED CONTRACT TO SUPPLY TORPEDO SYSTEM
17th Feb 202212:05 pmRNSDirector/PDMR Shareholding
2nd Feb 20224:20 pmRNSEBT purchase of shares
31st Jan 20225:30 pmRNSDirector/PDMR Shareholding
31st Jan 20224:00 pmRNSTotal Voting Rights
31st Jan 20222:15 pmRNSEBT Purchase
25th Jan 20224:40 pmRNSSecond Price Monitoring Extn
25th Jan 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20224:35 pmRNSDirector/PDMR Shareholding
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSInterim Report 2021
11th Jan 20226:21 pmRNSDirector/PDMR Shareholding
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20215:30 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSHalf Year Results
30th Nov 20214:24 pmRNSTotal Voting Rights
18th Nov 20217:00 amRNSEID Awarded Dismounted Soldier System Contract
29th Oct 20215:00 pmRNSTotal Voting Rights
15th Oct 20215:00 pmRNSDirector/PDMR Shareholding
13th Oct 20212:00 pmRNSDirector/PDMR Shareholding
5th Oct 20215:52 pmRNSDirector/PDMR Shareholding
5th Oct 20215:48 pmRNSBlock Listing Application
5th Oct 20215:41 pmRNSReplacement: Block listing Interim Review
5th Oct 20215:15 pmRNSHolding(s) in Company
5th Oct 202110:20 amRNSBlock listing Interim Review
30th Sep 20214:40 pmRNSSecond Price Monitoring Extn
30th Sep 20214:35 pmRNSPrice Monitoring Extension
30th Sep 20214:21 pmRNSTotal Voting Rights
20th Sep 20214:10 pmRNSResult of AGM
20th Sep 20217:00 amRNSAGM Statement & First Quarter Update
17th Sep 20214:27 pmRNSBlock listing Interim Review
9th Sep 20217:00 amRNSMass awarded £11m contract extension
26th Aug 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Aug 20212:22 pmRNSPDMR Shareholdings
20th Aug 20217:00 amRNSSEA wins £4.6m upgrade contract for overseas navy
18th Aug 20219:56 amRNSEBT Purchase
12th Aug 202112:50 pmRNSEBT Purchase
10th Aug 20215:00 pmRNSDirector Share Awards and Shareholdings
10th Aug 202110:51 amRNSEBT Purchase - Replacement
10th Aug 202110:50 amRNSEBT Purchase - Replacement
6th Aug 202111:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.